Streptomycin: Difference between revisions
(Replace manual dosing with dynamic SMW tables (Adult + Pediatric)) |
(Remove disease-specific entries now covered by AntibioticDose (6 sections)) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 5: | Line 5: | ||
==Adult Dosing== | ==Adult Dosing== | ||
===Infections, Bacterial=== | |||
*1-2 g/day IM divided q6-12h | |||
**Max: 2 g/day; Info: adjust dose based on serum levels | |||
**Renal dosing | |||
***Creatinine Clearance 50-80: give q24h | |||
***Creatinine Clearance 10-50: give q24-72h | |||
***Creatinine Clearance <10: give q72-96h | |||
===Indications by Disease=== | ===Indications by Disease=== | ||
{{#ask: [[Has DrugName::Streptomycin]] [[Has Population::Adult]] | {{#ask: [[Has DrugName::Streptomycin]] [[Has Population::Adult]] | ||
|?Treats disease=Disease | |?Treats disease=Disease | ||
|?Has Dose=Dose | |?Has Dose=Dose | ||
|?Has Context=Context | |?Has Context=Context | ||
|format=table | |format=table | ||
|limit=50 | |limit=50 | ||
|mainlabel=- | |mainlabel=- | ||
|headers=show | |headers=show | ||
|sort=Treats disease | |sort=Treats disease | ||
}} | }} | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
===Infections, Bacterial=== | |||
*20-40mg/kg IM q24h | |||
**Alternative: 20-40mg/kg IM 2x/wk | |||
**Maximum dose: 1 g/dose if q24h, or 1.5 g/dose if 2x/wk | |||
**Renal dosing | |||
***Creatinine Clearance 50-80: 7.5mg/kg give q24h | |||
***Creatinine Clearance 10-50: 7.5mg/kg give q24-72h | |||
***Creatinine Clearance <10: 7.5mg/kg give q72-96h | |||
===Indications by Disease=== | ===Indications by Disease=== | ||
{{#ask: [[Has DrugName::Streptomycin]] [[Has Population::Pediatric]] | {{#ask: [[Has DrugName::Streptomycin]] [[Has Population::Pediatric]] | ||
|?Treats disease=Disease | |?Treats disease=Disease | ||
|?Has Dose=Dose | |?Has Dose=Dose | ||
|?Has Context=Context | |?Has Context=Context | ||
|format=table | |format=table | ||
|limit=50 | |limit=50 | ||
|mainlabel=- | |mainlabel=- | ||
|headers=show | |headers=show | ||
|sort=Treats disease | |sort=Treats disease | ||
}} | }} | ||
Latest revision as of 11:08, 20 March 2026
General
- Type: Aminoglycoside
- Dosage Forms:
- IM
Adult Dosing
Infections, Bacterial
- 1-2 g/day IM divided q6-12h
- Max: 2 g/day; Info: adjust dose based on serum levels
- Renal dosing
- Creatinine Clearance 50-80: give q24h
- Creatinine Clearance 10-50: give q24-72h
- Creatinine Clearance <10: give q72-96h
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Plague | 1g IM q12h x10 days; Maximum dose: 2 g/day (adjust dose based on serum levels) | Plague |
| Tuberculosis | 15mg/kg IM q24h 5-7x/wk; Alternative: 25-30mg/kg IM 2-3x/wk | Active tuberculosis |
| Tularemia | 1g IM q12h x10 days; Maximum dose: 2 g/day (adjust dose based on serum levels) | Tularemia |
Pediatric Dosing
Infections, Bacterial
- 20-40mg/kg IM q24h
- Alternative: 20-40mg/kg IM 2x/wk
- Maximum dose: 1 g/dose if q24h, or 1.5 g/dose if 2x/wk
- Renal dosing
- Creatinine Clearance 50-80: 7.5mg/kg give q24h
- Creatinine Clearance 10-50: 7.5mg/kg give q24-72h
- Creatinine Clearance <10: 7.5mg/kg give q72-96h
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Plague | 15mg/kg IM q12h x10 days; Maximum dose: 2 g/day (adjust dose based on serum levels) | Plague |
| Tuberculosis | 20-40mg/kg IM q24h; Alternative: 20-40mg/kg IM 2x/wk; Maximum dose: 1 g/dose if q24h, or 1.5 g/dose if 2x/wk | Active tuberculosis |
| Tularemia | 15mg/kg IM q12h x10 days; Maximum dose: 2 g/day (adjust dose based on serum levels) | Tularemia |
Special Populations
- Pregnancy Rating: D
- Lactation: Probably Safe
- Monitoring parameters:
- BUN/creatinine at baseline, then periodically.
- Serum drug levels
- Urinanalysis
- Audiometry for high risk patients
Contraindications / Cautions
- Contraindicated:
- BCG live intravesical
- Cidofovir
- Streptozocin
- caution if hypersensitivity to sulfites
- caution if impaired vestibular function
- caution if impaired auditory function
- caution if concurrent ototoxic agents
- caution if concurrent neurotoxic agents
- caution if neuromuscular disease
- caution if renal impairment
- caution if dehydration
- caution if concurrent nephrotoxic agent use
- caution if electrolyte abnormalities
- caution if prolonged use
- caution in neonates or infants
- caution in elderly patients
Adverse Reactions
Serious
- Ototoxicity, auditory & vestibular
- Neurotoxicity
- Neuromuscular blockade
- Nephrotoxicity
- Anemia, hemolytic
- Pancytopenia
- Thrombocytopenia
- Anaphylaxis
- Angioedema
- Hypersensitivity reaction
- Exfoliative dermatitis
- Superinfection
Common
- Nausea and vomiting
- Vertigo
- Paresthesia, facial
- Rash
- Fever
- Urticaria
- Angioedema
- Eosinophilia
- Deafness
- Exfoliative dermatitis
- Anaphylaxis
- Azotemia
- Leukopenia
- Thrombocytopenia
- Pancytopenia
- Anemia, hemolytic
- muscle weakness
- Amblyopia
- Injection site reaction
Pharmacology
- Half-life: 5 hours
- Metabolism: Unknown; CYP450
- Excretion: Urine
- Mechanism of Action: Bactericidal (binds to 30S ribosomal subunit, inhibiting protein synthesis)
See Also
References
Epocrates